Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. [4] Specifically it is used for NSCLC …

Erlotinib (Tarceva) is a type of targeted therapy used to treat pancreatic cancer and non-small cell lung cancer. It is a tyrosine kinase inhibitor that works by blocking the kinase activity of a …

Mar 18, 2020 · Erlotinib is a tyrosine kinase receptor inhibitor approved by the US Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer and advanced pancreatic …

On October 18, 2016, the U.S. Food and Drug Administration modified the indication for erlotinib (TARCEVA, Astellas Pharm Global Development Inc.) for treatment of non-small cell lung …

Erlotinib is used for the treatment of metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) …

Erlotinib is a medication that stops cancer cells from growing. It treats non-small cell lung cancer and pancreatic cancer. Erlotinib comes in a tablet form that you can take by mouth with a …

This page contains brief information about erlotinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Erlotinib is a type of medicine known as a tyrosine kinase inhibitor. It works by targeting specific proteins on cancer cells. By blocking the action of these proteins, erlotinib can cause...

Erlotinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of …

Erlotinib blocks (inhibits) a protein called epidermal growth factor receptor (EGFR) that can cause the cancer to grow. Erlotinib can be used to treat non-small cell lung cancer (NSCLC) that has …